GROUP ANNUAL RESULTS FOR THE YEAR ENDED 30 JUNE 2025 Andy Hall, CEO & Dorette Neethling, CFO OVERVIEW ANDY HALL, CEO 2 PANADO PRODUCT OF THE YEAR Panado Syrups and Panado Adult effervescent pain relief TRANSFORMATION CHILD HEALTH ADULT PAIN RELIEF 3 PERFORMANCE FY2025 H2 vs H1 TURNOVER +7% TRADING PROFIT +30% TURNOVER +1% R9.8b TRADING PROFIT -4% R1.2b DIVIDEND +2% 280 cents HEPS +1% 626 cents HEPS +36% 4 CONSUMER REVENUE R1 802m +6% TRADING PROFIT R385m +6% 5 OTC REVENUE R2 442m -1% TRADING PROFIT R404m +5 ...